{"disease":{"id":"thrombotic-disorders","name":"thrombotic disorders"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06947707","title":"Safety and Efficacy of Edoxaban and Rivaroxaban to Cerebral Venous Thrombosis in Chinese Patients","phase":"","overall_status":"RECRUITING","enrollment_count":1486,"lead_sponsor_name":"Xuanwu Hospital, Beijing","has_results":false},{"nct_id":"NCT05819736","title":"Pharmacokinetics Study Of Rivaroxaban and Apixaban in Cancer Patients","phase":"","overall_status":"UNKNOWN","enrollment_count":400,"lead_sponsor_name":"Groupe Hospitalier Pitie-Salpetriere","has_results":false},{"nct_id":"NCT07450898","title":"Retrospective Analysis of Acute Pancreatitis After Percutaneous Mechanical Thrombectomy In Treatment Of Thrombotic Disorders","phase":"","overall_status":"RECRUITING","enrollment_count":10,"lead_sponsor_name":"RenJi Hospital","has_results":false},{"nct_id":"NCT03393481","title":"Prevention of Thromboembolic Events in Total Knee Replacement Patients","phase":"PHASE2","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":false}],"total":4},"guidelines":[],"source":"Drug Landscape verified database"}